Disseminated Mycobacterium haemophilum infection

The Lancet Infectious Diseases

Volumn 11, Issue 7, 2011, Pages 571-578

  Kelley, Colleen F ^a   Armstrong, Wendy S ^a   Eaton, Molly E ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CLARITHROMYCIN; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LEVOFLOXACIN; RIFABUTIN; TENOFOVIR; ZIDOVUDINE;

ABSCESS; ADULT; ANOREXIA; BONE MARROW TRANSPLANTATION; CASE REPORT; CELLULITIS; DISEASE COURSE; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEVER; GRAFT RECIPIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LUNG INFECTION; LYMPHADENITIS; MALAISE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM HAEMOPHILUM; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; THORAX RADIOGRAPHY; VIRUS LOAD; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; CELLULITIS; CLARITHROMYCIN; HIV; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INFECTIONS; OFLOXACIN; RIFABUTIN;

EID: 79959298170     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70029-9     Document Type: Review

References (89)

1. Sompolinsky D, Lagziel A, Rosenberg I Further studies of a new pathogenic mycobacterium (M haemophilum sp nov). Can J Microbiol 1979, 25:217-226.
2. Cohen YH, Amir J, Ashkenazi S, et al. Mycobacterium haemophilum and lymphadenitis in immunocompetent children, Israel. Emerg Infect Dis 2008, 14:1437-1439.
3. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996, 9:435-447.
4. Shah MK, Sebti A, Kiehn TE, Massarella SA, Sepkowitz KA Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001, 33:330-337.
5. Gouby A, Branger B, Oules R, Ramuz M Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J Med Microbiol 1988, 25:299-300.
6. Straus WL, Ostroff SM, Jernigan DB, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994, 120:118-125.
7. White MH, Papadopoulos EB, Small TN, Kiehn TE, Armstrong D Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation 1995, 60:957-960.
8. Yakrus MA, Straus WL DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis. J Clin Microbiol 1994, 32:1083-1084.
9. Kikuchi K, Bernard EM, Kiehn TE, Armstrong D, Riley LW Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J Clin Microbiol 1994, 32:1763-1767.
10. van Coppenraet LE Bruijnesteijn, Savelkoul PH, Buffing N, et al. Amplified fragment length polymorphism analysis of human clinical isolates of Mycobacterium haemophilum from different continents. Clin Microbiol Infect 2009, 15:924-930.
11. Hernandez-Divers SJ, Shearer D Pulmonary mycobacteriosis caused by Mycobacterium haemophilum and M marinum in a royal python. J Am Vet Med Assoc 2002, 220:1661-1663.
12. Jacob B, Debey BM, Bradway D Spinal intradural Mycobacterium haemophilum granuloma in an American Bison (Bison bison). Vet Pathol 2006, 43:998-1000.
13. Pai HH, Chen WC, Peng CF Isolation of non-tuberculous mycobacteria from hospital cockroaches (Periplaneta americana). J Hosp Infect 2003, 53:224-228.
14. Whipps CM, Dougan ST, Kent ML Mycobacterium haemophilum infections of zebrafish (Danio rerio) in research facilities. FEMS Microbiol Lett 2007, 270:21-26.
15. Murray PR Manual of clinical microbiology 2003, American Society for Microbiology Press, Washington DC. 8th edn.
16. Dawson DJ, Jennis F Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol 1980, 11:190-192.
17. Vadney FS, Hawkins JE Evaluation of a simple method for growing Mycobacterium haemophilum. J Clin Microbiol 1985, 22:884-885.
18. McBride JA, McBride ME, Wolf JE Evaluation of commercial blood-containing media for cultivation of Mycobacterium haemophilum. Am J Clin Pathol 1992, 98:282-286.
19. Bosma F, Deckers-Kocken JM, de Graaf SS, Schulin T, Melchers WJ, Hoogkamp-Korstanje JA Mycobacterium reverse hybridization line-probe assay used to diagnose disseminated Mycobacterium haemophilum infection in a child with acute lymphoblastic leukemia. Eur J Clin Microbiol Infect Dis 2004, 23:345-347.
20. van Coppenraet LS, Smit VT, Templeton KE, Claas EC, Kuijper EJ Application of real-time PCR to recognize atypical mycobacteria in archival skin biopsies: high prevalence of Mycobacterium haemophilum. Diagn Mol Pathol 2007, 16:81-86.
21. Wang SX, Sng LH, Leong HN, Tan BH Direct identification of Mycobacterium haemophilum in skin lesions of immunocompromised patients by PCR-restriction endonuclease analysis. J Clin Microbiol 2004, 42:3336-3338.
22. Samra Z, Kaufmann L, Zeharia A, et al. Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol 1999, 37:832-834.
23. Giulieri S, Morisod B, Edney T, et al. Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis 2011, 52:488-491.
24. Lindeboom JA, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R, Kuijper EJ Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis 2005, 41:1569-1575.
25. Minani TJC, Saubolle MA, Yu E, Sussland Z Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient. J Clin Microbiol 2010, 48:2636-2639.
26. Wolinsky E Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995, 20:954-963.
27. Dawson DJ, Blacklock ZM, Kane DW Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child. Med J Aust 1981, 2:289-290.
28. van Coppenraet LE Bruijnesteijn, Kuijper EJ, Lindeboom JA, Prins JM, Claas EC Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis 2005, 11:62-68.
29. Armstrong KL, James RW, Dawson DJ, Francis PW, Masters B Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr 1992, 121:202-205.
30. Lindeboom JA, Kuijper CF, van Furth M Inguinal lymphadenitis caused by Mycobacterium haemophilum in an immunocompetent child. Pediatr Infect Dis J 2007, 26:84-86.
31. Kiehn TE, White M Mycobacterium haemophilum: an emerging pathogen. Eur J Clin Microbiol Infect Dis 1994, 13:925-931.
32. Haimi-Cohen Y, Amir J, Eidlitz-Markus T, Steier D, Ben-Amitai D, Zeharia A Chronic cheek lesions: an unusual manifestation of nontuberculous mycobacterial cevicofacial infection. J Pediatr 2009, 155:746-748.
33. Da Mata O, Alfonzo R Perez, Natera I, Rdel C Sucre, Bello T, de Waard JH The diagnosis of two cases of cutaneous ulcer caused by infection with Mycobacterium haemophilum: direct identification in a clinical sample by polymerase chain reaction-restriction endonuclease analysis. Int J Dermatol 2008, 47:820-823.
34. Campbell LB, Maroon M, Pride H, Adams DC, Tyler WB Mycobacterium haemophilum in an immunosuppressed child. Pediatr Dermatol 2006, 23:481-483.
35. Rogers PL, Walker RE, Lane HC, et al. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am J Med 1988, 84:640-642.
36. Endo T, Takahashi T, Suzuki M, et al. Mycobacterium haemophilum infection in a Japanese patient with AIDS. J Infect Chemother 2001, 7:186-190.
37. Friedli A, Krischer J, Hirschel B, Saurat JH, Pechere M An annular plaque due to Mycobacterium haemophilum infection in a patient with AIDS. J Am Acad Dermatol 2000, 43:913-915.
38. Hirsch R, Miller SM, Kazi S, Cate TR, Reveille JD Human immunodeficiency virus-associated atypical mycobacterial skeletal infections. Semin Arthritis Rheum 1996, 25:347-356.
39. Lefkowitz RA, Singson RD Considering Mycobacterium haemophilum in the differential diagnosis for lytic bone lesions in AIDS patients who present with ulcerating skin lesions. Skeletal Radiol 1998, 27:334-336.
40. Martinelli C, Farese A, Carocci A, Giorgini S, Tortoli E, Leoncini F First case of Mycobacterium haemophilum infection in an AIDS patient in Italy. J Eur Acad Dermatol Venereol 2004, 18:83-85.
41. Olsen RJ, Cernoch PL, Land GA Mycobacterial synovitis caused by slow-growing nonchromogenic species: eighteen cases and a review of the literature. Arch Pathol Lab Med 2006, 130:783-791.
42. Soubani AO, al-Marri M, Forlenza S Successful treatment of disseminated Mycobacterium haemophilum infection in a patient with AIDS. Clin Infect Dis 1994, 18:475-476.
43. Thibert L, Lebel F, Martineau B Two cases of Mycobacterium haemophilum infection in Canada. J Clin Microbiol 1990, 28:621-623.
44. Phowthongkum P, Puengchitprapai A, Udomsantisook N, Tumwasorn S, Suankratay C Spindle cell pseudotumor of the brain associated with Mycobacterium haemophilum and Mycobacterium simiae mixed infection in a patient with AIDS: the first case report. Int J Infect Dis 2008, 12:421-424.
45. Elsayed S, Read R Mycobacterium haemophilum osteomyelitis: case report and review of the literature. BMC Infect Dis 2006, 6:70.
46. Holton J, Nye P, Miller R Mycobacterium haemophilum infection in a patient with AIDS. J Infect 1991, 23:303-306.
47. Geisler WM, Harrington RD, Wallis CK, Harnisch JP, Liles WC Broad spectrum of dermatologic manifestations caused by Mycobacterium haemophilum infection. Arch Dermatol 2002, 138:229-230.
48. Gibson MK, Villano SA, Huff CA, Cofrancesco J Recrudescence of cutaneous Mycobacterium haemophilum lesions following tetanus immunization. Clin Infect Dis 1999, 28:919-920.
49. Manabe YC, Breen R, Perti T, Girardi E, Sterling TR Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy. J Infect Dis 2009, 199:437-444.
50. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008, 8:516-523. for the International Network for the Study of HIV-associated IRIS.
51. Lawn SD, Lipman MC, Easterbrook PJ Immune reconstitution disease associated with mycobacterial infections. Curr Opin HIV AIDS 2008, 3:425-431.
52. Branger B, Gouby A, Oules R, et al. Mycobacterium haemophilum and Mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol 1985, 23:46-49.
53. Davis BR, Brumbach J, Sanders WJ, Wolinsky E Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 1982, 97:723-724.
54. Moulsdale MT, Harper JM, Thatcher GN, Dunn BL Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle 1983, 64:29-36.
55. Jang EY, Lee SO, Choi SH, et al. Case of pyomyositis due to Mycobacterium haemophilum in a renal transplant recipient. J Clin Microbiol 2007, 45:3847-3849.
56. Lin JH, Chen W, Lee JY, Yan JJ, Huang JJ Disseminated cutaneous Mycobacterium haemophilum infection with severe hypercalcaemia in a failed renal transplant recipient. Br J Dermatol 2003, 149:200-202.
57. Keller M, Mak A, Thibert L, Rene P, Klein MB Mycobacterium haemophilum epididymal abscess in a renal transplant patient. J Clin Microbiol 2008, 46:2459-2460.
58. Castro-Silva AN, Freire AO, Grinbaum RS, et al. Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment. Transpl Infect Dis 2011, 13:33-37.
59. Rajpara A, Sri J, Driscoll M Mycobacterium haemophilum: cutanoeus nodules in a renal transplant patient. Dermatol Online J 2010, 16:3.
60. Malouf MA, Glanville AR The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999, 160:1611-1616.
61. Fairhurst RM, Kubak BM, Pegues DA, et al. Mycobacterium haemophilum infections in heart transplant recipients: case report and review of the literature. Am J Transplant 2002, 2:476-479.
62. Lederman C, Spitz JL, Scully B, et al. Mycobacterium haemophilum cellulitis in a heart transplant recipient. J Am Acad Dermatol 1994, 30:804-806.
63. Plemmons RM, McAllister CK, Garces MC, Ward RL Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. Clin Infect Dis 1997, 24:995-997.
64. Modi D, Pyatetsky D, Edward DP, et al. Mycobacterium haemophilum: a rare cause of endophthalmitis. Retina 2007, 27:1148-1151.
65. Sagi L, Leshem E, Barzilai A, Baum S, Har-Zahav Y, Rahav G Mycobacterium haemophilum infection presenting as bilateral cellulitis and annular lesion in a heart transplant recipient. Isr Med Assoc J 2010, 12:57-58.
66. Millar MJ, Bulliard C, Balachandran C, Maloof AJ Mycobacterium hemophilum infection presenting as filamentary keratopathy in an immunocompromised adult. Cornea 2007, 26:764-766.
67. Ward MS, Lam KV, Cannell PK, Herrmann RP Mycobacterial central venous catheter tunnel infection: a difficult problem. Bone Marrow Transplant 1999, 24:325-329.
68. Darling TN, Sidhu-Malik N, Corey GR, Allen NB, Kamino H, Murray JC Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. Br J Dermatol 1994, 131:376-379.
69. Kamboj M, Louie E, Kiehn T, Papanicolaou G, Glickman M, Sepkowitz K Mycobacterium haemophilum infection after alemtuzumab treatment. Emerg Infect Dis 2008, 14:1821-1823.
70. Lott JP, Werth VP, Kovarik CL Cutaneous Mycobacterium haemophilum infection in iatrogenically immunocompromised patients without transplantation. J Am Acad Dermatol 2008, 59:139-142.
71. Shih JY, Hsueh PR, Chang YL, Lin SF, Teng LJ, Luh KT Pyomyositis due to Mycobacterium haemophilum in a patient with polymyositis and long-term steroid use. Clin Infect Dis 1998, 26:505-507.
72. Tan HH, Tan A, Theng C, Ng SK Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a dermatology clinic in Singapore. Ann Acad Med Singapore 2004, 33:532-536.
73. Teh CL, Kong KO, Chong AP, Badsha H Mycobacteriuçemophilum infection in an SLE patient on mycophenolate mofetil. Lupus 2002, 11:249-252.
74. von Stebut E, Wiest K, Braeuninger W Chronic infiltrates and persisting ulcerations on the arms and legs. Arch Dermatol 2005, 141:897-902.
75. Swart RM, van Ingen J, van Soolingen D, Slingerland R, Hendriks WD, den Hollander JG Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists. Emerg Infect Dis 2009, 15:1700-1701.
76. Bekou V, Buchau A, Flaig M, Ruzicka T, Hogardt M Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man. BMC Dermatol 2011, 11:3.
77. Smith S, Taylor GD, Fanning EA Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury. Clin Infect Dis 2003, 37:e100-e101.
78. White DA, Kiehn TE, Bondoc AY, Massarella SA Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host. Am J Respir Crit Care Med 1999, 160:1366-1368.
79. McBride ME, Rudolph AH, Tschen JA, et al. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections. Arch Dermatol 1991, 127:276-277.
80. Males BM, West TE, Bartholomew WR Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome. J Clin Microbiol 1987, 25:186-190.
81. Busam KJ, Kiehn TE, Salob SP, Myskowski PL Histologic reactions to cutaneous infections by Mycobacterium haemophilum. Am J Surg Pathol 1999, 23:1379-1385.
82. Woods GL Susceptibility testing for mycobacteria. Clin Infect Dis 2000, 31:1209-1215.
83. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
84. Bernard EM, Edwards FF, Kiehn TE, Brown ST, Armstrong D Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother 1993, 37:2323-2326.
85. Paech V, Lorenzen T, von Krosigk A, et al. Remission of cutaneous Mycobacterium haemophilum infection as a result of antiretroviral therapy in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis 2002, 34:1017-1019.
86. Becherer P, Hopfer RL Infection with Mycobacterium haemophilum. Clin Infect Dis 1992, 14:793.
87. Lindeboom JA, Kuijper EJ, van Coppenraet ES Bruijnesteijn, Lindeboom R, Prins JM Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007, 44:1057-1064.
88. Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, Samra Z, Kaufman L, Amir J Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J 2008, 27:920-922.
89. Lindeboom JA Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis 2011, 52:180-184.